{"id":55021,"date":"2025-11-21T14:22:35","date_gmt":"2025-11-21T08:52:35","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=55021"},"modified":"2025-11-21T14:22:59","modified_gmt":"2025-11-21T08:52:59","slug":"concord-biotech-q2-results-2025","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/concord-biotech-q2-results-2025\/","title":{"rendered":"Concord Biotech Q2 Results 2025 Highlights: Net Profit Falls 33.59% &#038; Revenue Down 20.35% YoY"},"content":{"rendered":"<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong><em>Click and Sign Up to Get Live Updates on Q2 Results&nbsp;<\/em><\/strong><\/a><\/p><p><strong>Concord Biotech <\/strong><strong><em>Q2 Results FY26<\/em><\/strong>: During Q2 FY26, Concord Biotech&#8217;s profit decreased 33.59% YoY, while revenue decreased by 20.35% YoY. The company posted robust numbers, with Q2 PAT at \u20b963.58 crores and revenue at \u20b9247.06 crores. <a href=\"https:\/\/univest.in\/stocks\/concordbio\/concord-biotech-ltd-share-price-today\">Concord Biotech<\/a> announced its Q2 results on 13th November 2025.&nbsp;&nbsp;<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/concord-biotech-q2-results-2025\/#Concord_Biotech_Q2_Results_FY26_Extracts_of_FY25_FY26_Consolidated_Figures\" title=\"Concord Biotech Q2 Results FY26: Extracts of FY25 &amp; FY26 (Consolidated Figures)\">Concord Biotech Q2 Results FY26: Extracts of FY25 &amp; FY26 (Consolidated Figures)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/concord-biotech-q2-results-2025\/#Concord_Biotech_Q2_Results_FY26_Extracts_of_FY25_FY26_Standalone_Figures\" title=\"Concord Biotech Q2 Results FY26: Extracts of FY25 &amp; FY26 (Standalone Figures)\">Concord Biotech Q2 Results FY26: Extracts of FY25 &amp; FY26 (Standalone Figures)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/concord-biotech-q2-results-2025\/#Concord_Biotech_Q2_Results_FY26_Highlights_Q2_FY26_vs_FY25\" title=\"Concord Biotech Q2 Results FY26 Highlights (Q2 FY26 vs FY25)\">Concord Biotech Q2 Results FY26 Highlights (Q2 FY26 vs FY25)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/concord-biotech-q2-results-2025\/#Concord_Biotech_Share_Price_Performance\" title=\"Concord Biotech Share Price Performance\">Concord Biotech Share Price Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/concord-biotech-q2-results-2025\/#What_Analysts_Expect_Post_Q2_Results\" title=\"What Analysts Expect Post Q2 Results?\">What Analysts Expect Post Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/concord-biotech-q2-results-2025\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Concord_Biotech_Q2_Results_FY26_Extracts_of_FY25_FY26_Consolidated_Figures\"><\/span><strong>Concord Biotech Q2 Results FY26: Extracts of FY25 &amp; FY26 (Consolidated Figures)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td rowspan=\"2\"><strong>Particulars<\/strong><\/td><td colspan=\"2\"><strong>Quarter Ended<\/strong><\/td><\/tr><tr><td><strong>30-09-2025<\/strong><\/td><td><strong>30-09-2024<\/strong><\/td><\/tr><tr><td><strong>Revenue from Operations<\/strong><\/td><td>\u20b9247.06<\/td><td>\u20b9310.18<\/td><\/tr><tr><td><strong>Profit Before Tax (PBT)<\/strong><\/td><td>\u20b9101.84<\/td><td>\u20b9146.70<\/td><\/tr><tr><td><strong>Profit After Tax (PAT)<\/strong><\/td><td>\u20b963.58<\/td><td>\u20b995.74<\/td><\/tr><\/tbody><\/table><\/figure><p>(Figures in crores)<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Concord_Biotech_Q2_Results_FY26_Extracts_of_FY25_FY26_Standalone_Figures\"><\/span><strong>Concord Biotech Q2 Results FY26: Extracts of FY25 &amp; FY26 (Standalone Figures)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td rowspan=\"2\"><strong>Particulars<\/strong><\/td><td colspan=\"2\"><strong>Quarter Ended<\/strong><\/td><\/tr><tr><td><strong>30-09-2025<\/strong><\/td><td><strong>30-09-2024<\/strong><\/td><\/tr><tr><td><strong>Revenue from Operations<\/strong><\/td><td>\u20b9247.06<\/td><td>\u20b9310.18<\/td><\/tr><tr><td><strong>Profit Before Tax (PBT)<\/strong><\/td><td>\u20b9103.97<\/td><td>\u20b9146.70<\/td><\/tr><tr><td><strong>Profit After Tax (PAT)<\/strong><\/td><td>\u20b962.90<\/td><td>\u20b998.70<\/td><\/tr><\/tbody><\/table><\/figure><p>(Figures in crores)<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Concord_Biotech_Q2_Results_FY26_Highlights_Q2_FY26_vs_FY25\"><\/span><strong>Concord Biotech Q2 Results FY26 Highlights (Q2 FY26 vs FY25)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><ul class=\"wp-block-list\"><li>Concord Biotech clocked Q2 FY26 consolidated revenue of \u20b9247.06 crores vs \u20b9310.18 crores.\u00a0<\/li>\n\n<li>On the profit front, Concord Biotech earned a consolidated PAT of \u20b963.58 crore in Q2 FY26. During FY25, the company\u2019s PAT stood at \u20b995.74 crore.<\/li>\n\n<li>According to the consolidated figures, Concord Biotech&#8217;s quarterly PAT decreased by 33.59% YoY, while revenue decreased by 20.35%.<\/li>\n\n<li>Concord Biotech clocked Q2 FY26 standalone revenue of \u20b9247.06 crores vs \u20b9310.18 crores.\u00a0<\/li>\n\n<li>On the profit front, Concord Biotech earned a standalone PAT of \u20b962.90 crore in Q2 FY26. During FY25, the company\u2019s PAT stood at \u20b998.70 crore.<\/li>\n\n<li>According to the standalone figures, Concord Biotech&#8217;s quarterly PAT decreased by 36.28% YoY, while revenue decreased by 20.35%.<\/li><\/ul><p><strong><em>Download the <\/em><\/strong><a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest iOS App<\/em><\/strong><\/a><strong><em> or <\/em><\/strong><a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest Android App<\/em><\/strong><\/a><strong><em> to get daily stock recommendations and insightful research pieces!<\/em><\/strong><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Concord_Biotech_Share_Price_Performance\"><\/span><strong>Concord Biotech Share Price Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>On the opening bell on 21st November 2025, Concord Biotech shares opened at \u20b91,444.10 per share. However, the initial gains have since eroded, and Concord Biotech shares are currently trading at \u20b91,424.60 per share, lower than the opening price.&nbsp;&nbsp;&nbsp;&nbsp;<\/p><p>Considering the long-term performance, Concord Biotech shares have yielded returns of approximately -5.66% over the past 6 months and -28.46% over the past 1 year. Over the maximum timeframe, Concord Biotech shares delivered a 51.10% return to investors.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Analysts_Expect_Post_Q2_Results\"><\/span><strong>What Analysts Expect Post Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Following Concord Biotech&#8217;s robust Q2 results, analysts expect its share price to rise. According to analysts, Concord Biotech&#8217;s share price is expected to reach \u20b91,510.30 per share in the coming year; however, in a downturn, it could fall to \u20b91,402.30 per share. However, one must ignore stock market volatility and invest in Concord Biotech&#8217;s shares after thorough research.&nbsp;<\/p><p><strong><em>Disclaimer:<\/em><\/strong><em> Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/nestle-q2-results-2025\">Nestle Q2 Results FY26: Q2 PAT Falls 17.38% to \u20b9743.17 Crore; Revenue Up 10.57% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/inspira-enterprise-india-ipo-details\">Inspira Enterprise India IPO Details: Everything You Should Know about<\/a>&nbsp;<\/p><p><a href=\"https:\/\/univest.in\/blogs\/swaraj-engines-q2-results-fy26\">Swaraj Engines Q2 Results FY26: Q2 PAT Rises 8.88% to \u20b949 Crore; Revenue Up 8.62% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/hdb-financial-q2-results-2025\">HDB Financial Q2 Results FY26: Q2 PAT Falls 1.5% to \u20b9581 Crore; Revenue Up 13.42% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/bel-gears-q2-results-expectations\">BEL Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/paytm-q2-results-expectations\">Paytm Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/blue-dart-q2-results-expectations\">Blue Dart Gears Up for Q2 Reveal on 28th October; Check Key Expectations Here<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Click and Sign Up to Get Live Updates on Q2 Results&nbsp; Concord Biotech Q2 Results FY26: During Q2 FY26, Concord Biotech&#8217;s profit decreased 33.59% YoY, while revenue decreased by 20.35% YoY. The company posted robust numbers, with Q2 PAT at \u20b963.58 crores and revenue at \u20b9247.06 crores. Concord Biotech announced its Q2 results on 13th<\/p>\n","protected":false},"author":23,"featured_media":55022,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3479],"class_list":["post-55021","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-concord-biotech-q2-results-2025"],"metadata":{"_edit_lock":["1763715180:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_primary_category":["842"],"rank_math_seo_score":["77"],"rank_math_title":["Concord Biotech Q2 Results 2025: Net Profit Falls by 33.59% YoY"],"rank_math_description":["Discover the recent updates on the Concord Biotech Q2 results for FY26. Q2 profit falls by 33.59% YoY to \u20b963.58 crore, and revenue decreased by 20.35% YoY."],"rank_math_focus_keyword":["Concord Biotech Q2 Results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["55022"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["4748"],"_wp_page_template":["default"],"rs_page_bg_color":[""],"rank_math_canonical_url":["https:\/\/univest.in\/blogs\/concord-biotech-q2-results-2025"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/21141933\/Concord-Biotech-Q2-Results-2025-Net-Profit-Falls-by-33.59-YoY.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/55021","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=55021"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/55021\/revisions"}],"predecessor-version":[{"id":55023,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/55021\/revisions\/55023"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/55022"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=55021"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=55021"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=55021"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}